LMAT
LeMaitre Vascular Inc
NASDAQ: LMAT · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$103.57
+1.24% today
Updated 2026-07-29
Market cap
$2.32B
P/E ratio
37.39
P/S ratio
9.07x
EPS (TTM)
$2.72
Dividend yield
0.84%
52W range
$78 – $118
Volume
0.3M
LeMaitre Vascular Inc (LMAT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$103.57
12-Month target
$95.25
2030 Target
—
Intrinsic (DCF)
$54.96
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 24.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.